Patients have routine access to more cancer drugs as prices drop, according to NICE
The National Institute for Health and Care Excellence (NICE) reported [...]
The National Institute for Health and Care Excellence (NICE) reported [...]
We are disappointed to learn that the National Institute for [...]
In recent years, drugs that target the vascular endothelial growth [...]
In the following video, Dr Robert J. Motzer from Memorial Sloan [...]
Everolimus (Afinitor) has been recommended by the National Institute for [...]
A recent study published online in BioMed Central Cancer shows [...]
A new drug that targets a key enzyme that cancer [...]
A study published in the European Journal of Cancer shows that [...]
This week saw the initiation of a global phase III [...]
The European Commission has approved Kisplyx (lenvatinib) for the treatment [...]